medigraphic.com

2008, Number S1

<< Back Next >>

Rev Mex Anest 2008; 31 (S1)

Novel techniques in treatment of intractable obstetric hemorrhage

Wali A

Language: English
References: 24
Page: 48-50
PDF size: 88.60 Kb.


Text Extraction

Intractable obstetric hemorrhage can occur in the antepartum, intrapartum, or postpartum period. Common causes of antepartum hemorrhage include placental abruption, placenta previa, uterine rupture, and vasa previa. Common causes of postpartum hemorrhage include uterine atony, genital trauma, retained placenta, placenta accreta, and uterine inversion.
In the antepartum period, vaginal delivery is pursued if there is no fetal or maternal compromise. Cesarean section is reserved for severe maternal hemorrhage or worsening coagulopathy. Blood product availability and continuous electronic fetal monitoring are essential to successful and safe outcome.


REFERENCES

  1. Czer LS, Shoemaker WC. Optimal hematocrit value in critically ill postoperative patient. Surg Gynecol Obstet 1978;147:363-368.

  2. Oats JN, Vasey DP, Waldron BA. Effects of ketamine on the pregnant uterus. Br J Anaesth 1979;51:1163-1166.

  3. Suresh MS SDAJHPNS. Comparison of etomidate with thiopental for induction of anesthesia at cesarean section. Anesthesiology 1986;65(3A):A400.

  4. Andrews WW RSMMeal. Effect of type of anesthesia on blood loss at elective repeat cesarean section. Am J Perinatology 1992;9:197-200.

  5. Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol 1997;104:372-375.

  6. Sharma SK PJWJ. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg 1997;85:94-98.

  7. Baker BW. Blood conservation, obstetrics, and Jehovahs Witnesses. Anesthesiology Clinics of North America 1998;16:375-384.

  8. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-2703.

  9. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-747.

  10. Wali A, Suresh MS, Gregg AR. Antepartum hemorrhage. Anesthetic and Obstetric Management of High-Risk Pregnancy, Ed. Datta S, 3rd ed., 2004;87111.

  11. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion 2000;40:1165-1168.

  12. 12.Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000;92:1531-1536.

  13. Chestnut DH. Obstetric anesthesia. principles and practice. Second Edition ed. St. Louis, Missouri: Mosby, Inc., 1999.

  14. Harnett MJ, Hepner DL, Datta S, Kodali BS. Effect of amniotic fluid on coagulation and platelet function in pregnancy: an evaluation using thromboelastography. Anaesthesia. 2005;60:1068-72.

  15. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90. Review.

  16. Frolich MA, Gibby G, Mahla ME. Thromboelastography to assess coagulation in the thrombocytopenic parturient. Can J Anaesth. 2003;50:853. No abstract available.

  17. Sharma SK, Vera RL, Stegall WC, Whitten CW. Management of a postpartum coagulopathy using thrombelastography. J Clin Anesth 1997;9:243-7.

  18. Tanchev S, Platikanov V, Karadimov D. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period. Acta Obstet Gynecol Scand 2005;84:402-403.

  19. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.

  20. Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol 1998;179:1043-1046.

  21. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomized placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:971-975.

  22. Surbek DV, Fehr PM, Hosli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo- controlled trial. Obstet Gynecol 1999;94:255-258.

  23. Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomized trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-695.

  24. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for obstetrical bleeding. Int J Gyn Obstet 2001;74:139-142.




2020     |     www.medigraphic.com